应激期相位熵在标准PET心肌灌注显像变量之上的增量预后价值
本研究纳入3963例接受药物负荷-静息82Rb PET心肌灌注显像的连续患者,评估相位变量对全因死亡率的预后价值。中位随访5年间923例(23%)死亡,应激期相位熵在调整标准临床及PET-MPI变量(含心肌血流储备)后仍与全因死亡率独立相关(异常熵>43.8%的校正HR 1.44,95%CI 1.18-1.75,p<0.001),且加入标准变量后显著改善死亡预测的判别能力(p<0.001)。
要点
- 应激期相位熵与全因死亡率独立相关,异常熵(>43.8%)校正HR 1.44(95%CI 1.18-1.75)。
- 相位熵最低十分位组与最高十分位组年化死亡率分别为2.6%/年与12.0%/年,相差4.6倍。
- 异常应激期相位熵在心肌血流储备正常与受损患者中均能分层全因死亡风险(均p<0.001)。
核心结论
- 应激期相位熵在包括心肌血流储备在内的标准PET-MPI变量之外,与全因死亡率独立且增量相关。
- 相位熵可自动获取,作者建议将其纳入PET-MPI研究的临床报告中以改善患者风险预测。
研究设计与样本
- 连续纳入接受药物负荷-静息82Rb PET研究的患者,相位变量由QPET软件自动获取。
- 采用Cox比例风险分析评估相位变量与全因死亡率的关联,共纳入3963例患者(中位年龄71岁,57%为男性)。
主要发现
- 中位随访5年间923例(23%)死亡,年化死亡率随应激期相位熵升高而增加,熵最低与最高十分位组间相差4.6倍(2.6 vs 12.0%/年)。
- 异常应激期相位熵(最佳截断值43.8%)在心肌血流储备正常与受损患者中均能分层全因死亡风险(均p<0.001)。
- 三个相位变量中仅应激期相位熵在调整标准临床与PET-MPI变量(含心肌血流储备及相位变量的负荷-静息变化)后与全因死亡率显著相关:二分类模型校正HR 1.44(异常熵>43.8%,95%CI 1.18-1.75,p<0.001),连续模型每增加5%校正HR 1.05(95%CI 1.01-1.10,p=0.030)。
- 将应激期相位熵加入标准PET-MPI变量显著改善全因死亡预测的判别能力(p<0.001),其他相位变量未改善(p>0.1)。
关键数值与推荐
- 应激期相位熵预测全因死亡的最佳截断值为43.8%。
- 异常应激期相位熵(>43.8%)的校正HR为1.44(95%CI 1.18-1.75,p<0.001)。
- 应激期相位熵每增加5%的校正HR为1.05(95%CI 1.01-1.10,p=0.030)。
临床怎么用
- 作者认为相位熵可自动获取,可纳入PET-MPI研究的临床报告以改善患者风险预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Phase analysis can assess left ventricular dyssynchrony. The independent prognostic value of phase variables over positron emission tomography myocardial perfusion imaging (PET-MPI) variables including myocardial flow reserve (MFR) has not been studied. The aim of this study was to explore the prognostic value of phase variables for predicting mortality over standard PET-MPI variables. METHODS: Consecutive patients who underwent pharmacological stress-rest 82Rb PET study were enrolled. All PET-MPI variables including phase variables (phase entropy, phase bandwidth, and phase standard deviation) were automatically obtained by QPET software (Cedars-Sinai, Los Angeles, CA). Cox proportional hazard analyses were used to assess associations with all-cause mortality (ACM). RESULTS: In a total of 3963 patients (median age 71 years; 57% male), 923 patients (23%) died during a median follow-up of 5 years. Annualized mortality rates increased with stress phase entropy, with a 4.6-fold difference between the lowest and highest decile groups of entropy (2.6 vs. 12.0%/year). Abnormal stress phase entropy (optimal cutoff value, 43.8%) stratified ACM risk in patients with normal and impaired MFR (both p < 0.001). Among three phase variables, only stress phase entropy was significantly associated with ACM after the adjustment of standard clinical and PET-MPI variables including MFR and stress-rest change of phase variables, whether modeled as binary variables (adjusted hazard ratio, 1.44 for abnormal entropy [> 43.8%]; 95%CI, 1.18-1.75; p < 0.001) or continuous variables (adjusted hazard ratio, 1.05 per 5% increase; 95%CI, 1.01-1.10; p = 0.030). The addition of stress phase entropy to the standard PET-MPI variables significantly improved the discriminatory power for ACM prediction (p < 0.001), but the other phase variables did not (p > 0.1). CONCLUSION: Stress phase entropy is independently and incrementally associated with ACM beyond standard PET-MPI variables including MFR. Phase entropy can be obtained automatically and included in clinical reporting of PET-MPI studies to improve patient risk prediction.
引用
- Kuronuma K, Miller RJH, Van Kriekinge SD, et al. Incremental prognostic value of stress phase entropy over standard PET myocardial perfusion imaging variables. Eur J Nucl Med Mol Imaging. 2023. PMID: 37428217. doi:10.1007/s00259-023-06323-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。